Integra Lifesciences Holdings (IART) Treasury Shares (2009 - 2026)
Integra Lifesciences Holdings (IART) reported Treasury Shares of $687.1 million for Q1 2026, little changed on a YoY basis from $690.4 million in Q1 2025, and little changed sequentially from $689.2 million in Q4 2025.
Integra Lifesciences Holdings (IART) Treasury Shares (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings (IART) has 18 years of Treasury Shares data on file, last reported at $687.1 million in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares changed 0.47% year-over-year to $687.1 million; the trailing twelve-month figure through Mar 2026 stood at $687.1 million (changed 0.47% YoY), and the FY2025 full-year result was $689.2 million, changed 0.32% from the prior year.
- Treasury Shares held at $687.1 million in Q1 2026, from $689.2 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $14.5 million in Q3 2024 to a low of $6.8 million in Q1 2022.
- A 5-year average of $11.6 million and a median of $12.8 million in 2023 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares soared 78.39% in 2023 and decreased 0.47% in 2026, its largest moves.
- Tracing IART's Treasury Shares over 5 years: stood at $362.9 million in 2022, then jumped by 78.39% to $647.3 million in 2023, then increased by 6.81% to $691.4 million in 2024, then dropped by 0.32% to $689.2 million in 2025, then decreased by 0.31% to $687.1 million in 2026.
- Business Quant data shows IART's Treasury Shares at $687.1 million in Q1 2026, $689.2 million in Q4 2025, and $690.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 16.94 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 7.70 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 263.29 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 83.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 14.05 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.51 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 515.00 Mn |
| 10 | Integra Lifesciences Holdings | 1.71 Bn | 1.45 Bn | 216.98 Mn | 14.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 687.10 Mn |
| Mar 31, 2026 | 14.40 Mn |
| Mar 31, 2026 | 687.10 Mn |
| Mar 31, 2026 | 14.40 Mn |
| Dec 31, 2025 | 689.21 Mn |
| Dec 31, 2025 | 14.40 Mn |
| Dec 31, 2025 | 14.40 Mn |
| Dec 31, 2025 | 689.21 Mn |
| Sep 30, 2025 | 14.42 Mn |
| Sep 30, 2025 | 14.42 Mn |
| Sep 30, 2025 | 690.00 Mn |
| Sep 30, 2025 | 690.00 Mn |
| Jun 30, 2025 | 14.42 Mn |
| Jun 30, 2025 | 690.00 Mn |
| Jun 30, 2025 | 690.00 Mn |
| Jun 30, 2025 | 14.42 Mn |
| Mar 31, 2025 | 690.38 Mn |
| Mar 31, 2025 | 14.42 Mn |
| Mar 31, 2025 | 14.42 Mn |
| Mar 31, 2025 | 690.38 Mn |